E. Lisowski

Pharmacokinetic features, immunogenicity, and toxicity of B43(anti-CD19)-pokeweed antiviral protein immunotoxin in cynomolgus monkeys.

W. Evans, N. Tumer, J. Irvin, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

In Vivo Pharmacokinetic Features, Toxicity Profile, and Chemosensitizing Activity of α-Cyano-β-hydroxy-β- methyl-N-(2,5-dibromophenyl)propenamide (LFM-A13), a Novel Antileukemic Agent Targeting Bruton’s Tyrosine Kinase

F. Uckun, A. Vassilev, B. Waurzyniak, 2002 .

In Vivo Toxicity, Pharmacokinetics, and Anti-Human Immunodeficiency Virus Activity of Stavudine-5′-(p-Bromophenyl Methoxyalaninyl Phosphate) (Stampidine) in Mice

F. Uckun, S. Pendergrass, B. Waurzyniak, 2002, Antimicrobial Agents and Chemotherapy.

Toxicity and Pharmacokinetics of Stampidine in Mice and Rats

F. Uckun, B. Waurzyniak, T. Venkatachalam, 2003, Arzneimittelforschung.

In vivo pharmacokinetic features, toxicity profile, and chemosensitizing activity of alpha-cyano-beta-hydroxy-beta- methyl-N-(2,5-dibromophenyl)propenamide (LFM-A13), a novel antileukemic agent targeting Bruton's tyrosine kinase.

F. Uckun, A. Vassilev, B. Waurzyniak, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.